logo-loader

Gilead Sciences, Inc.

Receive alerts
Market:
NASDAQ
Market Cap:
$84.68 billion
Price
66.93 USD
Change
-0.22%
52 weeks high
70.50
52 weeks low
60.32

In brief

Gilead Sciences, Inc. is a biopharmaceutical company that discovers, develops and commercializes therapeutics. The Company sells and distributes Truvada, Viread, Emtriva, Hepsera and AmBisome in Asia, Australia, Europe, Latin America, the Middle East and New Zealand, through its commercial teams, third party distributors or partners.